Abstract
New series of pyrido[2,3-d]pyrimidines such as; 5-(4-aryl-5-sulfanyl-4H-[1,2,4]triazol-3-yl) 1H,3H,8H-pyrido[2,3-d]pyrimidine-2,4,7-triones 6, 7; S-[3-(2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl)-4-(4-substituted phenyl)-4H-[1,2,4]triazol-5-yl]-2-(4-phenylpiperazin-1-yl)ethanethioates 10, 11; 2,4,7-trioxo-N′-[(4-substituted piperazin-1-yl)acetyl]-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidine-5-carbohydrazides 13–16 and N′-arylidene-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidine-5-carbohydrazides 17–19 was synthesized through the reaction of the key intermediate 2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidine-5-carbohydrazide 3 with different reagents. The structures of the newly synthesized compounds were elucidated through microanalysis, IR, 1H NMR, 13C NMR, and mass spectroscopy. These compounds have been subjected to in vitro antitumor evaluation by bleomycin-dependant DNA damage assay. The most active antitumor compound 6 was selected for further in vivo evaluation of antineoplastic activity against Ehrlich ascites carcinoma in mice. It was observed that our target compound has a potent antitumor activity.
Similar content being viewed by others
References
Agrawal VK, Sohgaura R, Khadikar PV (2002) QSAR studies on biological activity of piritrexim analogues against Pc DHFR. Bioorg Med Chem 10:2919–2926
Al-Soud YA, Al-Dweri MN, Al-Masoudi NA (2004) Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives. IL Farm 59:775–783
Anderson GL, Shim JL, Broom AD (1977) Pyridopyrimidines. 6-Nucleophilic substitutions in the pyrido[2,3-d]pyrimidine series. J Org Chem 42:993–996
Ayyad SEN, Makki MS, Al-kayal NS, Basaif SA, El-Foty KO, Asiri AM, Alarif WM, Badria FA (2011a) Cytotoxic and protective DNA damage of three new diterpenoids from the brown alga Dictyota dichotoma. Eur J Med Chem 46:175–182
Ayyad SEN, Ezmirly ST, Basaif SA, Alarif WM, Badria AF, Badria FA (2011b) Antioxidant, cytotoxic, antitumor and protective DNA damage metabolites from the red sea brown alga Sargassum sp. Pharmacogn Res 3:160–165
Bala A, Kar B, Haldar PK, Mazumder UK, Bera S (2010) Evaluation of anticancer activity of Cleome gynandra on Ehrlich’s ascites carcinoma treated mice. J Ethnopharmacol 129:131–134
Chan DCM, Fu H, Forsch RA, Queener SF, Rosowsky A (2005) Design, synthesis and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with ω-carboxyalkoxy or ω-carboxy-1-alkynyl substitution in the side chain. J Med Chem 48:4420–4431
Cordeu L, Cubedo E, Bandres E, Rebollo A, Saenz X, Chozas H, Dominguez MV, Echeverria M, Mendivil B, Sanmartin C, Palop JA, Font M, Foncillas JG (2007) Biological profile of new apoptotic agents based on 2,4-pyrido[2,3-d]pyrimidine derivatives. Bioorg Med Chem 15:1659–1669
De P, Baltas M, Theys DL, Bruyere C, Kiss R, Belval FB, Saffon N (2010) Synthesis and anticancer activity evaluation of 2(4-alkoxyphenyl)cyclopropyl hydrazides and triazolo phthalazines. Bioorg Med Chem 18:2537–2548
El-Nassan HB (2011) Synthesis and antitumor activity of novel pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-one derivatives. Eur J Med Chem 46:2031–2036
Formagio ASN, Tonin LTD, Foglio MA, Madjarof C, Carvalho JE, Costa WF, Cardoso FP, Sarragiotto MH (2008) Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) β-carboline derivatives. Bioorg Med Chem 16:9660–9667
Gangjee A, Adair O, Queener SF (2001) Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido[2,3-d]pyrimidines as dihydrofolate reductase inhibitors. Bioorg Med Chem 9:2929–2935
Grande F, Aiello F, Grazia OD, Brizzi A, Garofalo A, Neamati N (2007) Synthesis and antitumor activities of a series of novel quinoxaline hydrazides. Bioorg Med Chem 15:288–294
Guo CC, Tong RB, Li KL (2004) Chloroalkyl piperazine and nitrogen mustard porphyrins: synthesis and anticancer activity. Bioorg Med Chem 12:2469–2475
Joska TM, Anderson AC (2006) Structure activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads. Antimicrob Agents Chemother 50:3435–3443
Kurumurthy C, Rao PS, Swamy BV, Kumar GS, Rao PS, Narsaiah B, Velatooru LR, Pamanji R, Rao JV (2011) Synthesis of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives and their anticancer activity. Eur J Med Chem 46:3462–3468
Mohamed NR, El-Saidi MMT, Ali YM, Elnagdi MH (2007) Utility of 6-amino-2-thiouracil as a precursor for the synthesis of bioactive pyrimidine derivatives. Bioorg Med Chem 15:6227–6235
Qureshi S, Al-Shabana O, Al-Harbi M, Al-Bekairi A, Raza M (2001) Boric acid enhances in vivo Ehrlich ascites carcinoma cell proliferation in Swiss albino mice. Toxicology 165:1–11
Sanmartin C, Echeverria M, Mendivil B, Cordeu L, Cubedo E, Foncillas JG, Font M, Palop JA (2005) Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agent and apoptosis inducers. Bioorg Med Chem 13:2031–2044
Shi F, Ding J, Zhang S, Hao WJ, Cheng C, Tu S (2011) Substrate controlled chemoselective synthesis and potent cytotoxic activity of novel 5,6,7-triarylpyrido[2,3-d]pyrimidin-4-one derivatives. Bioorg Med Chem Lett 21:1554–1558
Tu S, Zhang J, Zhu X, Xu J, Zhang Y, Wang Q, Jia R, Jiang B, Zhang J (2006) New potential inhibitors of cyclin dependent kinase 4: design and synthesis of pyrido[2,3-d]pyrimidine derivatives under microwave irradiation. Bioorg Med Chem Lett 16:3578–3581
Zink M, Lanig H, Troschutz R (2004) Structural variations of piritrexim, a lipophilic inhibitor of human dihydrofolate reductase: synthesis, antitumor activity and molecular modeling investigations. Eur J Med Chem 39:1079–1088
Acknowledgments
We would like to thank Prof. Farid A. Badria, Professor of Pharmacognosy, Faculty of Pharmacy, Mansoura University, for his cooperation in performing the biologic screening.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gineinah, M.M., Nasr, M.N.A., Badr, S.M.I. et al. Synthesis and antitumor activity of new pyrido[2,3-d]pyrimidine derivatives. Med Chem Res 22, 3943–3952 (2013). https://doi.org/10.1007/s00044-012-0396-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-012-0396-0